Organic potassium salts
Medchemexpress LLC Bleximenib oxalate | 2866179-95-3 | 98.0% | 689.82 | 1 MG
Bleximenib oxalate is an orally active and selective menin-KMT2A inhibitor with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. It can inhibit the proliferation and induce apoptosis and differentiation of tumor cells, making it suitable for research into tumors such as leukemia.
- Orally active and selective menin-KMT2A inhibitor
- Inhibits proliferation and induces apoptosis and differentiation of tumor cells
- Reduces expression of MEIS1, PBX3, FLT3, and JMJD1C
- Exhibits anti-tumor activity in mouse models of leukemia
Medchemexpress LLC N,N'-dinitrosopiperazine | 140-79-4 | MFCD00014615 | 99.9% | C4H8N4O2 | 10MG
N,N'-dinitrosopiperazine (CAS 140-79-4) is a nitrosated piperazine research chemical reported as a carcinogen with specificity for nasopharyngeal epithelium. Supplied as a high-purity solid for laboratory research, it is used in studies of nitrosamine-related carcinogenesis and disease models.
- High purity typically 99.9% (supplier reported)
- Available in small milligram quantities suitable for research
- Solid compound with molecular formula C4H8N4O2
- Used in studies of nitrosamine-induced carcinogenesis
- Comes with supplier safety and handling documentation
Selleck Chemical LLC Bromotetramisole Oxalate
(-)-p-Bromotetramisole Oxalate (L-p-Bromotetramisole Oxalate) is a potent and non-specific alkaline phosphatase inhibitor
Alkali Scientific Potassium Acetate, 2.5 Kg
Potassium Acetate, Laboratory Grade, is offered in a 2.5 kg volume and is widely used in laboratory settings for buffering solutions, pH control, and chemical synthesis. This compound is essential for creating potassium-based buffers and for reactions requiring an acetate ion as a reactant. Potassium acetate serves in biological applications, such as the preparation of buffers for enzymatic reactions and the stabilization of various biochemical processes. The high purity of this reagent ensures consistency and reliability in experimental results. It is also used in the synthesis of various compounds and plays a key role in organic chemistry and biochemistry research.
Cambridge Isotope Laboratories POTASSIUM PHOSPHOENOL PYRUVATE (2,3-13C2, 99%), 0.05 G
POTASSIUM PHOSPHOENOL PYRUVATE (2,3-13C2, 99%), 0.05 G
Medchemexpress LLC Acesulfame potassium | 55589-62-3 | MFCD00043833 | 99.38% | 100 G
Acesulfame potassium | 55589-62-3 | MFCD00043833 | 99.38% | 100 G
Aobchem Potassium Acetate | ≥95% | CAS 127-08-2 | C2H3KO2 | 1kg
Potassium Acetate | ≥95% | CAS 127-08-2 | C2H3KO2 | 1kg
Chem-Impex International, Inc. Phthalimide potassium salt | 1074-82-4 | MFCD00005887 | 100G
Phthalimide potassium salt, 1074-82-4, MFCD00005887, 100G
TARGETMOL CHEMICALS INC Naloxegol oxalate 50MG
Also available in 1 mL, 5 mg, 10 mg, 25 mg and bulk. Please contact Fisher for quotes. Naloxegol oxalate (NKTR-118) is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation. Purity 99.82%
Apexbio Technology LLC Naftidrofuryl oxalate 3200-06-4 100mg
Naftidrofuryl oxalate (CAS 3200-06-4) is a small-molecule antagonist of the 5-HT2 receptor modulating serotonergic signaling pathways implicated in vascular regulation By inhibiting 5-HT2-mediated responses this compound affects the dilation of peripheral and cerebral blood vessels Preclinical studies suggest that Naftidrofuryl oxalate may enhance cellular oxidative processes potentially by influencing cellular energy metabolism pathways It is widely utilized in the study and experimental treatment of peripheral vascular and cerebrovascular disorders
Medchemexpress LLC Naloxegol oxalate | 1354744-91-4 | 99.9% | C36H55NO15 | 5 MG
Naloxegol oxalate is an orally active, peripherally acting μ-opioid receptor antagonist (target Ki 7.42 nmol/L). It inhibits opioid binding to gastrointestinal μ-opioid receptors, alleviating opioid-induced gastrointestinal hypomotility, delayed transit, hypertonicity, and increased fluid reabsorption. It is applicable for research into opioid-induced constipation.
- Orally active
- Peripherally acting μ-opioid receptor antagonist
- Inhibits opioid binding to gastrointestinal μ-opioid receptors
- Alleviates opioid-induced gastrointestinal hypomotility and related issues
- Applicable to research on opioid-induced constipation
- High affinity binding to μ and κ-opioid receptors in vitro
- Low affinity to δ-opioid receptors in vitro
- No significant activity at non-opioid targets in vitro
- Available in solid and solution forms
![Medchemexpress LLC N-(2-chlorophenyl)-6-(piperidin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide oxalate | 1198408-78-4 | MFCD28023573 | 99.0% | 444.87 g/mol | C21H21ClN4O5 | 1 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000240341.png-250.jpg)
Medchemexpress LLC N-(2-chlorophenyl)-6-(piperidin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide oxalate | 1198408-78-4 | MFCD28023573 | 99.0% | 444.87 g/mol | C21H21ClN4O5 | 1 MG
LDN-211904 oxalate is the oxalate salt of a research small molecule described as a potent, reversible EphB3 inhibitor for biochemical and cellular studies. It is provided in milligram quantities for laboratory research, with a reported molecular weight of 444.87 g/mol and CAS 1198408-78-4. Not for clinical or human use.
- Potent, reversible EphB3 inhibitor (IC50 ≈ 79 nM).
- Reported molecular weight 444.87 g/mol and CAS 1198408-78-4.
- High purity suitable for research (>99.0%).
- Demonstrated metabolic stability in mouse liver microsomes.
- Supplied in research-scale quantities (for example, 1 mg).